VALIDATION OF THE USE OF BAYESIAN-ANALYSIS IN THE OPTIMIZATION OF GENTAMICIN THERAPY FROM THE COMMENCEMENT OF DOSING

被引：18

作者：

CHRYSTYN, H ^{[1
]}

机构：

[1] UNIV BRADFORD,PHARM POSTGRAD SCH,BRADFORD BD7 1DP,W YORKSHIRE,ENGLAND

来源：

DRUG INTELLIGENCE & CLINICAL PHARMACY | 1988年 / 22卷 / 01期

关键词：

D O I：

10.1177/106002808802200112

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：49 / 53

页数：5

共 27 条

[1]

BENET LZ, 1985, GOODMAN GILMANS PHAR, P1663

[2] SIMPLIFIED ACCURATE METHOD FOR ANTIBIOTIC ASSAY OF CLINICAL SPECIMENS [J].

BENNETT, JV ;

BRODIE, JL ;

BENNER, EJ ;

KIRBY, WMM .

APPLIED MICROBIOLOGY, 1966, 14 (02) :170-&

[3] INDIVIDUALIZING GENTAMICIN DOSAGE REGIMENS IN BURN PATIENTS WITH GRAM-NEGATIVE SEPTICEMIA - COST-BENEFIT-ANALYSIS [J].

BOOTMAN, JL ;

WERTHEIMER, AI ;

ZASKE, D ;

ROWLAND, C .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (03) :267-272

[4]

BURTON ME, 1986, CLIN PHARMACY, V5, P143

[5] COMPARISON OF DRUG DOSING METHODS [J].

BURTON, ME ;

VASKO, MR ;

BRATER, DC .

CLINICAL PHARMACOKINETICS, 1985, 10 (01) :1-37

[6]

BURTON ME, 1984, CLIN PHARMACOL THER, V35, P230

[7] PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].

COCKCROFT, DW ;

GAULT, MH .

NEPHRON, 1976, 16 (01) :31-41

[8]

GILMAN TM, 1986, DRUG INTEL CLIN PHAR, V20, P469

[9]

GODLEY PJ, 1986, DRUG INTEL CLIN PHAR, V20, P468

[10]

JELLIFFE RW, 1983, CLIN PHARMACOL THER, V33, P255

← 1 2 3 →